Autonomic nervous system-dependent and -independent cardiovascular effects of exendin-4 infusion in conscious rats. - Wikidata - wikimedia - TriplyDB

Autonomic nervous system-dependent and -independent cardiovascular effects of exendin-4 infusion in conscious rats.

Autonomic nervous system-dependent and -independent cardiovascular effects of exendin-4 infusion in conscious rats.

http://www.wikidata.org/entity/Q36735857

about

Exendin-4 increases blood glucose levels acutely in rats by activation of the sympathetic nervous system Cardiovascular and hemodynamic effects of glucagon-like peptide-1.The role of incretins in glucose homeostasis and diabetes treatment.Selective targeting of glucagon-like peptide-1 signalling as a novel therapeutic approach for cardiovascular disease in diabetes Investigation of the haemodynamic effects of exenatide in healthy male subjects.The cardiovascular effects of GLP-1 receptor agonists.Cardiovascular biology of the incretin system.Effects of exenatide and liraglutide on heart rate, blood pressure and body weight: systematic review and meta-analysis.Emerging cardiovascular actions of the incretin hormone glucagon-like peptide-1: potential therapeutic benefits beyond glycaemic control?Possible involvement of GLP-1(9-36) in the regional haemodynamic effects of GLP-1(7-36) in conscious rats.The autonomic nervous system and cardiac GLP-1 receptors control heart rate in mice.Effects of intravenous exenatide in type 2 diabetic patients with congestive heart failure: a double-blind, randomised controlled clinical trial of efficacy and safety.Long-Acting GLP-1 Receptor Agonist Exenatide Influence on the Autonomic Cardiac Sympatho-Vagal Balance.

P2860

Q33840311-5D0A17AF-C8F4-4CE2-9CBB-D6312175F505 Q33993725-32D9E9D9-5DBF-4E7F-B826-751FA9872C63 Q34901533-F82C210B-42E3-4858-B588-FC980642364C Q34994502-C15B380A-0471-458D-8925-A17C0147EAE2 Q36336020-517048BB-2C18-4090-A2A3-B88B175B22D0 Q36368998-0F014524-240E-41D8-B2E0-4B125B0633DF Q36484283-65CE75A5-8C5B-4DC6-ACE5-3C4F8D3F63EB Q36584204-BEE15233-7258-48CE-B8B8-6CCE53BE2FA8 Q37395298-E543A682-3432-41A3-8417-D802F72A7B5D Q41809232-D60743AF-ADA9-46EE-9CEC-4B4281034B02 Q46906226-AF5BE046-E55A-4AF8-AC31-8646DBF63C9D Q51368060-1CDD098D-339D-451E-8F15-89E495FCEC4B Q55090958-A7508F57-AB03-4EEF-8098-01C9B39BA8DE

P2860

Autonomic nervous system-dependent and -independent cardiovascular effects of exendin-4 infusion in conscious rats.

http://www.wikidata.org/entity/Q36735857

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

2008年论文

@zh

2008年论文

@zh-cn

name

Autonomic nervous system-depen ...... -4 infusion in conscious rats.

@ast

Autonomic nervous system-depen ...... -4 infusion in conscious rats.

@en

type

label

Autonomic nervous system-depen ...... -4 infusion in conscious rats.

@ast

Autonomic nervous system-depen ...... -4 infusion in conscious rats.

@en

prefLabel

Autonomic nervous system-depen ...... -4 infusion in conscious rats.

@ast

Autonomic nervous system-depen ...... -4 infusion in conscious rats.

@en

P1433

Q36735857-57335DDA-2769-4F8F-ADDC-490D9E5488CC

P1476

Q36735857-05A89E24-5D23-46A3-A49E-CF2EA98C73DB

P2093

Q36735857-2B1B2BA9-B80C-40A7-8A58-D1E55BC2CF61

Q36735857-2F1354B0-8E40-4F8F-96DB-C98820971B4F

Q36735857-6102283F-E877-4715-B5BE-D1979C41A312

Q36735857-B94BE9D0-903A-4846-AE94-5F5006BE4F84

P2860

Q36735857-06C62A6A-1444-401E-AACE-7609668BFB34

Q36735857-0F44736F-E628-431F-9D78-4390D912B3EC

Q36735857-1B04CAA5-15AD-4CCE-ABAA-4CAE072E2E11

Q36735857-244A63A5-889A-40BF-8A03-AEEF50EFF0FD

Q36735857-281F99DA-C96E-40F6-9989-4F1EC5A3704D

Q36735857-2C3BDC45-DB1D-4C5D-849B-7AC9635716DD

Q36735857-2F1F793F-4AF9-4DD5-AA05-8846845208EE

Q36735857-310239F6-1F76-4AF1-AD0C-897D2869A534

Q36735857-34C3251D-5F7D-440B-BA24-CD7CCD560AB2

Q36735857-4863ECE2-DA6C-4EB2-89EA-11FA53C509EB

P304

Q36735857-87DB5EE6-58B0-4B57-B91A-98B5CF1DFB49

P31

Q36735857-90DED123-D464-4D01-A297-984E26C2399C

P356

Q36735857-E7BDF531-6771-4316-ADB0-E28FD4404C2C

P407

Q36735857-2783D6DB-FFF3-400B-B244-D885413DCF84

P433

Q36735857-0B9B6F39-7035-4F4F-9A23-A5F2257DF64D

P478

Q36735857-8AB6A7EA-0C6A-4039-B143-350B986ECF99

P577

Q36735857-F774C664-8895-42ED-A3DB-D0DCB471FCFA

P5875

Q36735857-AFD4509D-29E2-4DEC-8932-C82A2E171629

P698

Q36735857-FF87B688-F44E-4384-AA27-4AFAFCF854F0

P932

Q36735857-DC868524-302C-40A7-A7CD-33C965EF1693

P356

P1433

British Journal of Pharmacology

P1476

Autonomic nervous system-depen ...... -4 infusion in conscious rats.

@en

P2093

J E March

http://www.w3.org/2001/XMLSchema#string

P A Kemp

http://www.w3.org/2001/XMLSchema#string

S M Gardiner

http://www.w3.org/2001/XMLSchema#string

T Bennett

http://www.w3.org/2001/XMLSchema#string

P2860

Effects of indomethacin on the regional haemodynamic responses to low doses of endothelins and sarafotoxin

Interactions between neural mechanisms, the renin-angiotensin system and vasopressin in the maintenance of blood pressure during water deprivation: studies in Long Evans and Brattleboro rats

Glucagon-like peptide-1 receptor stimulation increases blood pressure and heart rate and activates autonomic regulatory neurons

Local, exendin-(9-39)-insensitive, site of action of GLP-1 in canine ileum.

The glucagon-like peptides.

Pharmacology of exenatide (synthetic exendin-4): a potential therapeutic for improved glycemic control of type 2 diabetes.

Glucagon-like peptide-1: the basis of a new class of treatment for type 2 diabetes.

Incretin mimetics and DPP-IV inhibitors for the treatment of type 2 diabetes.

Exenatide: an incretin mimetic for the treatment of type 2 diabetes mellitus.

Glucagon-like peptide-1-responsive catecholamine neurons in the area postrema link peripheral glucagon-like peptide-1 with central autonomic control sites.

P304

60-71

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/BJP.2008.75

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

154

http://www.w3.org/2001/XMLSchema#string

P577

2008-03-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5541531

http://www.w3.org/2001/XMLSchema#string

P698

18311183

http://www.w3.org/2001/XMLSchema#string

P932

2438985

http://www.w3.org/2001/XMLSchema#string